BEIJING, June 11, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing over RMB27.1 million to repurchase 595,600 ordinary shares on June 10, 2026. With this latest repurchase, the Company has made over RMB1.76 billion in share repurchases year-to-date in 2026. This effort underscores the Company’s ongoing commitment to delivering value to shareholders. On March 18, 2026, the Board approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company’s shares (including ADSs) over the extended term of the program through August 28, 2027, in a sign of confidence about the Company’s continued growth...

TAICHUNG CITY, Taiwan, June 11, 2026 (GLOBE NEWSWIRE) — Agencia Comercial Spirits Ltd (NASDAQ: AGCC) (“Agencia” or the “Company”), a Taiwan-based importer and distributor of whisky products, today announced that its Indonesian subsidiary, PT. AGCC AITECH INDONESIA (“AGCC Indonesia”), has entered into additional electricity supply agreements with PT PLN (Persero) (“PLN”), the Indonesian state-owned electricity company, in connection with the Company’s planned AI computing infrastructure project in Indonesia. Together with electricity supply arrangements previously entered into by AGCC Indonesia for the project, the latest agreements establish a dual-feed power supply configuration for the planned data center, with each feed rated at 55,400 kVA. The electricity supply arrangements are intended to support the Company’s staged development...

New long-term share-based incentive programme With reference to the offering circular (the “Offering Circular”) published by InstallatørGruppen A/S (“InstallatørGruppen” or the “Company”, and together with its consolidated subsidiaries, the “Group”) as described in company announcement 1-2026 dated 3 June 2026, the Board of Directors of InstallatørGruppen has today implemented a new long-term incentive programme (the “LTIP”). The LTIP is designed and structured around the concept of retaining members of the Executive Management and other eligible employees while also creating an incentive for a positive share price development for the benefit of the Company’s shareholders. The LTIP grants comprise stock options which entitle the participant, subject to vesting occurring, to be allocated a number of shares in the Company, equivalent...

Banks and other monetary policy counterparties need to ensure that they have the operational capacity and readiness to borrow money from the Riksbank, emphasised Governor Erik Thedéen when he took part in a panel discussion at the Stockholm International Banking Crisis Management Conference.  “The Riksbank’s monetary policy counterparties shall regard the Riksbank’s lending facilities and market operations as a natural part of their daily liquidity management. To ensure that banks can borrow from the Riksbank quickly and efficiently when needed, we are considering introducing mandatory test transactions, but as a first step, our counterparties are now recommended to voluntarily test their operational capacity by borrowing from the Riksbank.” The banks can test their operational capacity by borrowing any amount from the Riksbank’s lending...

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D.,...

INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D., Chief Executive OfficerDate/Time:...

INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

PRESS RELEASE                                         Share Buyback Transaction Details June 4 – June 10, 2026 Alphen aan den Rijn – June 11, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 61,431 of its own ordinary shares in the period from June 4, 2026, up to and including June 10, 2026, for €3.9 million and at an average share price of €63.23. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

Montrouge, June 11, 2026 Crédit Agricole Financement de l’Habitat SFH ANNOUNCES EARLY REPURCHASE OF EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17)* Crédit Agricole Financement de l’Habitat SFH (the “Issuer”) announces today the early repurchase (the « Repurchase ») with effect on June 16, 2026 (the « Repurchase Date ») of all of its outstanding EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17) (the « Notes ») pursuant to the Terms and Conditions of the Notes (the “Terms and Conditions”) included in the prospectus dated July 20, 2023, which was granted the visa n°23-326 by the Autorité des marchés financiers on July...